• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Healthcare·197A.T
Share

TAUNS LABORATORIES INC. Stocks

¥ 503Last Updated 21.08.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

¥ 325.58M

¥ 503
Key Takeaways

Risk factor

Modest price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

TAUNS Laboratories, Inc. is a company dedicated to the creation and production of in-vitro diagnostic pharmaceuticals and various types of measuring equipment. Additionally, the firm facilitates the international trade (import and export) of an extensive selection of instruments, covering industrial, medical, physical, and chemical measurement applications. Founded in April 1987, the company maintains its principal office in Izunokuni, Japan.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITD

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 197A.T is 409 and suggests 19.6% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

23.08.2026 21:01

Anthropic to Strengthen Founders' Rights and Unitree's 460% Surge: Key Takeaways on the IPO by August 23

23.08.2026 18:01

Investors' Magical Thinking: The Power of Rituals, Superstitions, and Luck in the Stock Market

23.08.2026 15:01

"Stop Drawing Colorful Charts": How to Make Plans in an Era of Change

22.08.2026 16:01

What's Happening in Small-Cap Stocks: Curaleaf's Offering, a New GLP-1 Drug, and a Defense IPO

22.08.2026 13:01

U.S. national debt weighs on the market; top model joins a Kazakhstani AI company; Nasdaq to open at night

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026